Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis
H Hussein, E Abbas, S Keshavarzi, R Fazelzad… - Radiology, 2023 - pubs.rsna.org
Background The best supplemental breast cancer screening modality in women at average
risk or intermediate risk for breast cancer with dense breast and negative mammogram …
risk or intermediate risk for breast cancer with dense breast and negative mammogram …
AGO recommendations for the diagnosis and treatment of patients with early breast cancer: update 2022
N Ditsch, A Wöcke, M Untch, C Jackisch, US Albert… - Breast Care, 2022 - karger.com
Abstract Introduction: The AGO (Arbeitsgemeinschaft Gynäkologische Onkologie, German
Gynecological Oncology Group) Task Force on Diagnosis and Treatment of Breast Cancer …
Gynecological Oncology Group) Task Force on Diagnosis and Treatment of Breast Cancer …
Performance of digital breast tomosynthesis, synthetic mammography, and digital mammography in breast cancer screening: a systematic review and meta-analysis
M Alabousi, A Wadera, M Kashif Al-Ghita… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Our objective was to perform a systematic review and meta-analysis comparing
the breast cancer detection rate (CDR), invasive CDR, recall rate, and positive predictive …
the breast cancer detection rate (CDR), invasive CDR, recall rate, and positive predictive …
[PDF][PDF] Arbeitsgemeinschaft Gynäkologische Onkologie recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023
TW Park-Simon, V Müller, C Jackisch, US Albert… - Breast Care, 2023 - karger.com
Background: Each year the interdisciplinary Arbeitsgemeinschaft Gynäkologische Onkologie
(AGO), German Gynecological Oncology Group Breast Committee on Diagnosis and …
(AGO), German Gynecological Oncology Group Breast Committee on Diagnosis and …
Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
Breast cancer (BC) is the most common female cancer and the second cause of death
among women worldwide. The 5-year relative survival rate recently improved up to 90% due …
among women worldwide. The 5-year relative survival rate recently improved up to 90% due …
Dedicated breast CT: state of the art—Part I. Historical evolution and technical aspects
Y Zhu, AM O'Connell, Y Ma, A Liu, H Li, Y Zhang… - European …, 2022 - Springer
Dedicated breast CT is an emerging 3D isotropic imaging technology for breast, which
overcomes the limitations of 2D compression mammography and limited angle …
overcomes the limitations of 2D compression mammography and limited angle …
Interval and subsequent round breast cancer in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography screening
S Hofvind, N Moshina, ÅS Holen, AS Danielsen, CI Lee… - Radiology, 2021 - pubs.rsna.org
Background Prevalent digital breast tomosynthesis (DBT) has shown higher cancer
detection rates and lower recall rates compared with those of digital mammography (DM) …
detection rates and lower recall rates compared with those of digital mammography (DM) …
Accuracy and effectiveness of mammography versus mammography and tomosynthesis for population-based breast cancer screening: a systematic review and meta …
RR Giampietro, MVG Cabral, SAM Lima, SAT Weber… - Scientific reports, 2020 - nature.com
We proposed to compare the accuracy and effectiveness of digital breast tomosynthesis
(DBT), plus digital or synthetic mammography, with digital mammography alone in women …
(DBT), plus digital or synthetic mammography, with digital mammography alone in women …
Artificial intelligence for digital breast tomosynthesis: Impact on diagnostic performance, reading times, and workload in the era of personalized screening
The ultimate goals of the application of artificial intelligence (AI) to digital breast
tomosynthesis (DBT) are the reduction of reading times, the increase of diagnostic …
tomosynthesis (DBT) are the reduction of reading times, the increase of diagnostic …
A randomised controlled trial of digital breast tomosynthesis vs digital mammography as primary screening tests: Screening results over subsequent episodes of the …
P Armaroli, A Frigerio, L Correale… - … Journal of Cancer, 2022 - Wiley Online Library
Proteus Donna is a randomised controlled trial aimed at prospectively evaluating screening
with digital breast tomosynthesis (DBT), including interval cancer detection (ICD) and cancer …
with digital breast tomosynthesis (DBT), including interval cancer detection (ICD) and cancer …